Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatiana Birman

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Seminars in Oncology|October 9, 2012
Use of preclinical models to assess the therapeutic potential of new drug candidates for bladder cancerDoron Amit, Ofer N Gofrit, Imad Matouk, et al.
International Journal of Clinical and Experimental Medicine|June 21, 2011
Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of IGF2-P3 and IGF2-P4 regulatory sequencesDoron Amit, Sagi Tamir, Tatiana Birman, et al.
Urology|July 18, 2006
Chemically induced bladder cancer--a sonographic and morphologic descriptionOfrer N Gofrit, Tatiana Birman, Anna Dinaburg, et al.
International Journal of Oncology|August 30, 2011
Regional therapy with DTA-H19 vector suppresses growth of colon adenocarcinoma metastases in the rat liverVladimir Sorin, Patricia Ohana, Aya Mizrahi, et al.
Hypertension (Dallas, Tex. : 1979)|August 23, 2006
Adult hypertension in intrauterine growth-restricted offspring of hyperinsulinemic rats: evidence of subtle renal damageMichael Bursztyn, Marie-Luise Gross, Tania Goltser-Dubner, et al.
ISRN Oncology|June 16, 2012
H19-promoter-targeted therapy combined with gemcitabine in the treatment of pancreatic cancerVladimir Sorin, Patricia Ohana, Jennifer Gallula, et al.
International Journal of Clinical and Experimental Medicine|November 13, 2010
Targeting diphtheria toxin and TNF alpha expression in ovarian tumors using the H19 regulatory sequencesAya Mizrahi, Abraham Hochberg, Smadar Amiur, et al.
Journal of Medical Case Reports|July 29, 2010
Treatment of ovarian cancer ascites by intra-peritoneal injection of diphtheria toxin A chain-H19 vector: a case reportAya Mizrahi, Abraham Czerniak, Patricia Ohana, et al.
International Journal of Clinical and Experimental Medicine|May 9, 2012
Transcriptional targeting of glioblastoma by diphtheria toxin-A driven by both H19 and IGF2-P4 promotersDoron Amit, Imad J Matouk, Iris Lavon, et al.
International Journal of Cancer|March 29, 2002
Use of H19 regulatory sequences for targeted gene therapy in cancerPatricia Ohana, Osaat Bibi, Imad Matouk, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Seminars in Oncology|October 9, 2012
Use of preclinical models to assess the therapeutic potential of new drug candidates for bladder cancerDoron Amit, Ofer N Gofrit, Imad Matouk, et al.
International Journal of Clinical and Experimental Medicine|June 21, 2011
Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of IGF2-P3 and IGF2-P4 regulatory sequencesDoron Amit, Sagi Tamir, Tatiana Birman, et al.
Urology|July 18, 2006
Chemically induced bladder cancer--a sonographic and morphologic descriptionOfrer N Gofrit, Tatiana Birman, Anna Dinaburg, et al.
International Journal of Oncology|August 30, 2011
Regional therapy with DTA-H19 vector suppresses growth of colon adenocarcinoma metastases in the rat liverVladimir Sorin, Patricia Ohana, Aya Mizrahi, et al.
Hypertension (Dallas, Tex. : 1979)|August 23, 2006
Adult hypertension in intrauterine growth-restricted offspring of hyperinsulinemic rats: evidence of subtle renal damageMichael Bursztyn, Marie-Luise Gross, Tania Goltser-Dubner, et al.
ISRN Oncology|June 16, 2012
H19-promoter-targeted therapy combined with gemcitabine in the treatment of pancreatic cancerVladimir Sorin, Patricia Ohana, Jennifer Gallula, et al.
International Journal of Clinical and Experimental Medicine|November 13, 2010
Targeting diphtheria toxin and TNF alpha expression in ovarian tumors using the H19 regulatory sequencesAya Mizrahi, Abraham Hochberg, Smadar Amiur, et al.
Journal of Medical Case Reports|July 29, 2010
Treatment of ovarian cancer ascites by intra-peritoneal injection of diphtheria toxin A chain-H19 vector: a case reportAya Mizrahi, Abraham Czerniak, Patricia Ohana, et al.
International Journal of Clinical and Experimental Medicine|May 9, 2012
Transcriptional targeting of glioblastoma by diphtheria toxin-A driven by both H19 and IGF2-P4 promotersDoron Amit, Imad J Matouk, Iris Lavon, et al.
International Journal of Cancer|March 29, 2002
Use of H19 regulatory sequences for targeted gene therapy in cancerPatricia Ohana, Osaat Bibi, Imad Matouk, et al.
Pageof 2